BioSapien is a biotech 3D-printing company developing a novel biodegradable implantable product that delivers active pharmaceutical agents. With reduced systemic side effects, MediChip is a 3D-printed biodegradable mesh that delivers drugs in a localized, sustained manner for cancer indications. MediChip’s flexible nature mostly targets the tumor cells and the hard-to-reach tumor sites by delivering the cancer drugs (for example, FDA-approved APIs, gemcitabine, and 5-FU) directly to the site of the tumor.